Non-invasive risk-based surveillance of hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease

已完结 10 由达姆发布于 2026/8/26 11:16:04

DOI:10.1136/gutjnl-2025-334981
作者：Jimmy Che-To Lai, Boyu Yang, Hye Won Lee, Huapeng Lin, Emmanuel A Tsochatzis, Salvatore Petta, Elisabetta Bugianesi, Masato Yoneda, Ming-Hua Zheng, Hannes Hagstr?m, Jerome Boursier, Jose Luis Calleja,
文献类型：期刊论文
补充材料：只需要正文

BMJ

Abstract：Background Metabolic dysfunction-associated steatotic liver disease (MASLD) affects over 30% of the general population and is the fastest growing cause of hepatocellular carcinoma (HCC). Cur

应助信息

1天前

春风吹

d414c7fda0fd11f1bfad34735aa3bc31.pdf 已采纳

1天前

Book学术机器人

2026/8/26 11:16:04 未找到该文献，机器人已退出，请等待人工下载

2026/8/26 11:16:04 Book学术AI机器人收到请求，开始寻找文献

2026/8/26 11:16:04 已向机器人发送请求

1天前

达姆发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Flexible Waterborne Acoustic Metasurface With Tunable Functionality